MedTrace Logo

Comparison of Tolerability Between Two Allergy Drops

NCT01390961 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2011-07-11

No results posted yet for this study

Summary

Comfort is compared between two allergy drops

Conditions

  • Allergic Conjunctivitis

Interventions

DRUG

alacaftadine and naphazoline HCl & pheniramine maleate

once a day

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Hom, Milton M., OD, FAAO

    lead INDIV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-12-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390961 on ClinicalTrials.gov